KLOW Blend

Mechanism: KLOW unifies angiogenic mapping, cellular movement, collagen reconstruction, and cytokine mitigation via MC1R receptor paths.

Sequence: BPC-157 / GHK-Cu / TB-500 / KPV Array

Recommended Dosage: Administered via 1mg to 2mg subcutaneous injection daily.

Tracking Cycle: Evaluated across precise 4-week experimental timelines to measure total cell stress reduction.